Skip to main content
BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
0.229
-0.039 (-14.59%)
At close: Dec 20, 2024, 4:00 PM
0.220
-0.009 (-3.89%)
After-hours: Dec 20, 2024, 5:44 PM EST

BioNexus Gene Lab Revenue

BioNexus Gene Lab had revenue of $2.63M in the quarter ending September 30, 2024, with 3.00% growth. This brings the company's revenue in the last twelve months to $9.26M, down -10.42% year-over-year. In the year 2023, BioNexus Gene Lab had annual revenue of $9.77M, down -10.60%.

Revenue (ttm)
$9.26M
Revenue Growth
-10.42%
P/S Ratio
0.44
Revenue / Employee
$308,662
Employees
30
Market Cap
4.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20239.77M-1.16M-10.60%
Dec 31, 202210.93M-2.43M-18.21%
Dec 31, 202113.36M1.97M17.31%
Dec 31, 202011.39M11.26M8,872.03%
Dec 31, 2019126.96K-85.37K-40.21%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
IT Tech Packaging 79.16M
CN Energy Group. 66.51M
Danimer Scientific 37.43M
Graphex Group 30.02M
Bon Natural Life 25.56M
Crown Electrokinetics 13.46M
Gulf Resources 12.80M
SenesTech 1.65M
Revenue Rankings

BGLC News

More News